{
  "zip": "20520",
  "sector": "Healthcare",
  "fullTimeEmployees": 24,
  "longBusinessSummary": "Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company in Finland. It has a pipeline of drug development projects focusing on acute trauma, cancer growth and spread, and inflammatory diseases. The company's lead product candidates are Traumakine, a recombinant human IFN beta-1a, which is in Phase III clinical trial for the treatment of acute respiratory distress syndrome (ARDS); and Clevegen, an immunotherapy candidate, designed to prevent tumor growth and metastasis that targets the tumor immune suppressor molecule; and D-ARDS, a diagnostic tool to estimate ARDS severity and to follow ARDS outcome. Faron Pharmaceuticals Oy has a collaboration with MediCity unit of Turku University Medical School. The company was founded in 2003 and is headquartered in Turku, Finland.",
  "city": "Turku",
  "phone": "358 2469 5151",
  "country": "Finland",
  "companyOfficers": [],
  "website": "http://www.faron.com",
  "maxAge": 1,
  "address1": "Joukahaisenkatu 6",
  "fax": "358 2469 5152",
  "industry": "Biotechnology",
  "address2": "Intelligate",
  "previousClose": 3.55,
  "regularMarketOpen": 3.55,
  "twoHundredDayAverage": 5.033142,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 3.55,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 3.55,
  "fiftyDayAverage": 3.5572727,
  "trailingAnnualDividendRate": null,
  "open": 3.55,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.157303,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 3.55,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 2000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 173439856,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 47,
  "priceToSalesTrailing12Months": null,
  "dayLow": 3.55,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 2000,
  "fiftyTwoWeekHigh": 6.4431,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 3.55,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 3.55,
  "exchange": "PNK",
  "shortName": "FARON PHARMACEUTICALS OY",
  "longName": "Faron Pharmaceuticals Oy",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "FPHAF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_36632718",
  "uuid": "8db2bb33-71ab-3a94-8fe6-966c692a042d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 46896700,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.12199,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.43552,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 26542009,
  "enterpriseValue": 166139104,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 3.55,
  "logo_url": "https://logo.clearbit.com/faron.com"
}